The Genomic and Proteomic Content of Cancer Cell-Derived Exosomes

por Henderson, Meredith C., Azorsa, David O.
Publicado 2012

Integration of Serum Protein Biomarker and Tumor Associated Autoantibody Expression Data Increases the Ability of a Blood-Based Proteomic Assay to Identify Breast Cancer

por Henderson, Meredith C., Hollingsworth, Alan B., Gordon, Kelly, Silver, Michael, Mulpuri, Rao, Letsios, Elias, Reese, David E.
Publicado 2016

Breast density does not impact the ability of Videssa(®) Breast to detect breast cancer in women under age 50

por Reese, David E., Henderson, Meredith C., Silver, Michael, Mulpuri, Rao, Letsios, Elias, Tran, Quynh, Wolf, Judith K.
Publicado 2017

A Combinatorial Proteomic Biomarker Assay to Detect Ovarian Cancer in Women

por Henderson, Meredith C, Silver, Michael, Borman, Sherri, Tran, Quynh, Letsios, Elias, Mulpuri, Rao, Reese, David E, Wolf, Judith K
Publicado 2018

NCI60 Cancer Cell Line Panel Data and RNAi Analysis Help Identify EAF2 as a Modulator of Simvastatin and Lovastatin Response in HCT-116 Cells

por Savas, Sevtap, Azorsa, David O., Jarjanazi, Hamdi, Ibrahim-Zada, Irada, Gonzales, Irma M., Arora, Shilpi, Henderson, Meredith C., Choi, Yun Hee, Briollais, Laurent, Ozcelik, Hilmi, Tuzmen, Sukru
Publicado 2011

Synthetic lethal RNAi screening identifies sensitizing targets for gemcitabine therapy in pancreatic cancer

por Azorsa, David O, Gonzales, Irma M, Basu, Gargi D, Choudhary, Ashish, Arora, Shilpi, Bisanz, Kristen M, Kiefer, Jeffrey A, Henderson, Meredith C, Trent, Jeffrey M, Von Hoff, Daniel D, Mousses, Spyro
Publicado 2009